New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
07:47 EDTTSROTESARO price target raised to $51 from $43 at RW Baird
Baird raised its price target on TESARO following its announced move into the immune-oncology space. The firm likes the deal and believes its fits nicely along its other businesses. Shares remain Outperform rated.
News For TSRO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
07:02 EDTTSROTESARO 3.4M share Secondary priced at $51.00
Subscribe for More Information
March 2, 2015
16:22 EDTTSROTESARO files to sell $150M of common stock
Subscribe for More Information
February 23, 2015
06:25 EDTTSROMedivation removed from Focus List at Citigroup
Subscribe for More Information
06:23 EDTTSROCiti ups TESARO price target to $79, adds to focus list
Subscribe for More Information
February 20, 2015
05:53 EDTTSROTESARO price target raised to $50 from $44 at Mizuho
Mizuho raised its price target for TESARO shares to $50 citing increased confidence and market opportunity for niraparib following the company's Q4 results. The firm expects approval for rolapitant in Q3 and reiterates a Buy rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use